Bits of technology from I.B.M.’s Watson are beginning to be used in actual products available to corporate clients. The cloud-based Strategic Intellectual Property Insight Platform “uses data mining, natural-language processing and analytics to pore through millions of patent filings and biomedical journals to look for chemical compounds used in drug discovery.” As a byproduct of this project, I.B.M. is contributing their research to the searchable NIH chemical database, which will ease access to information previously mired in paperwork.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
Tagsbiotech industry biotechnology BIO EVENT GMOs Food global food crisis Biotechnology Industry healthcare patent agriculture BIO International Convention climate change Plant biotechnology Benefits of biotech crops BIO health Sustainability biofuels FDA Health Care
- Most Popular
Latest VideoJohn Chambers, Vice Chairman, Head of Healthcare Investment Banking, ROTH Capital Partners View All >